Tilray Brands, Inc. - Common Stock (TLRY)

Tilray is building a new adult beverage category with hemp THC drinks, as alcohol declines and competition from Big Tobacco heats up.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Tilray (NASDAQ:TLRY) and its peers.

Germany became the world's top importer of medical cannabis, but political pressure could challenge telehealth-driven growth.

Cannabis news of the week: Texas targets hemp, DEA blames legal states, Argentina revamps REPROCANN, and Tilray expands in Europe.

Tilray's medical arm expands into Germany with launch of Good Supply brand, offering affordable and high-quality cannabis flower. TLRY stock up 2.33%

Tilray shares trade flat as company expands cannabis lineup with XMG Atomic Sours drinks and gummies.

Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.

Germany's cannabis access surges with 2,500 pharmacies and 211 grow clubs, but bans on edibles and retail sales still limit the market's full potential.

Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But recently, the industry has failed to do its job as it shed 14% over the past six months. This drawdown was worse than the S&P 500’s 6.2% fall.

Tilray shares dipped after Blue Point re-released its commuter-themed beer and launched a new whiskey under the Breckenridge brand.

The past, present, and future of the Canadian cannabis sector.